Data / Form D filings / Codagenix Inc.
Codagenix Inc.: Form D filing
Codagenix Inc., a biotechnology company in Farmingdale, NY, filed a Form D with the SEC in 2023. The latest, on February 27, 2023, reports $25 million sold of a $25 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3 BIOSCIENCE PARK DR., Farmingdale, NY, 11735
- Phone
- (631) 227-3932
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1967165
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 27, 2023 | New notice | $25,005,232 | $25,005,232 | 5 | Feb 10, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Charlie Robert Petty | Director | |
| Steven Robert Winick | Director | |
| Jill Robert Howe | Director | |
| John Robert Coleman | Executive Officer, Director | |
| Steffen Robert Mueller | Director | |
| Paul Robert Grint | Director | |
| Glenn Robert Rockman | Director | |
| Tyler Robert Cook | Executive Officer | |
| Lori Robert Rudolph-Owen | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Feb 27, 2023 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Codagenix Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.